+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compounded medicines and 'off label' prescribing - a case for more guidance

Compounded medicines and 'off label' prescribing - a case for more guidance

Australian Family Physician 38(1-2): 16-20

Interest by prescribers and pharmacists in the provision of individualised pharmaceutical therapy in the form of compounded medicines has grown in recent times. However, there have also been a number of case reports of patient harm associated with these medicines. To highlight areas for clinicians and pharmacists to consider when prescribing or dispensing compounded medicines, which are consistent with quality use of medicines principles. Regulators of pharmaceutical products have expressed concerns with the production, marketing and use of compounded medicines dispensed by pharmacists. This has prompted debate over the need for more regulation of these products. We propose an expansion of off label prescribing guidelines to include a risk based assessment of pharmaceutical quality, a consumer information/education strategy and the development of a code of practice for pharmacists engaging in compounding. These strategies recognise a shared responsibility among prescribers, dispensers and regulators to achieve contemporary quality, safety, and efficacy standards and support the quality use of compounded medicines.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 052269291

Download citation: RISBibTeXText

PMID: 19283230

Related references

Video: pediatric medicines--prescribing drugs "off-label". Science 322(5899): 209-209, 2008

Off-Label and Unlicensed Prescribing of Medicines in Paediatric Populations: Occurrence and Safety Aspects. Basic & Clinical Pharmacology & Toxicology 117(4): 215-218, 2016

Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation. Journal of Clinical Pharmacy and Therapeutics 39(2): 144-153, 2014

Prescribing safety: the case of inappropriate medicines. British Journal of General Practice 61(590): 542-543, 2012

Doctors' strategies in prescribing drugs: the case of mood-modifying medicines. Family Practice 23(1): 73-79, 2005

Intravenous fluid prescribing: Improving prescribing practices and documentation in line with NICE CG174 guidance. Bmj Quality Improvement Reports 3(1): -, 2014

Overcoming objections to prescribing compounded medications. International Journal of Pharmaceutical Compounding 16(6): 484-485, 2013

Risk and liabilities of prescribing compounded medications. Postgraduate Medicine 126(4): 178-180, 2014

National Prescribing Centre guidance on prescribing specials. Prescriber 23(3): 40-41, 2012

NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium. Bmj Open 2(1): E000671-E000671, 2012

Think twice before prescribing custom-compounded bioidentical hormone therapy. Journal of Women's Health 23(8): 631-633, 2014

Inappropriate prescribing of compounded antiobesity formulas in Brazil. Pharmacoepidemiology and Drug Safety 7(3): 207-212, 2004

Use of IR spectrophotometry in the quantitative analysis of drugs. IV. Assays of some compounded medicines. Acta Poloniae Pharmaceutica 35(6): 643-648, 1978

Cellular destruction, phytohormones and growth modulating enzymes production by Bacillus subtilis strain BC8 impacted by fungicides. Pesticide Biochemistry and Physiology 149: 8-19, 2018

Changes in clinical indications for community antibiotic prescribing for children in the UK from 1996 to 2006: will the new NICE prescribing guidance on upper respiratory tract infections just be ignored?. Archives of Disease in Childhood 94(5): 337-340, 2008